| Intrinsic Valuation of: KHC | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | -5 | Market Cap | $27B | |||||
| 2021 | - | - (-) | P/E Ratio | - | Total Asset | $82B | |||||
| 2022 | $2B | - (-) | Net Income | $-6B | Total Debt | $19B | |||||
| 2023 | $3B | 90.8% (89.7%) | EBITDA | $-4B | Total Liab | $40B | |||||
| 2024 | $3B | 1.9% (5.1%) | Opr Margin | 18.59 | Debt/Equity | 0.46 | |||||
| 2025 | $4B | 21.2% (25.6%) | PreTax Margin | 14.79 | BV/Share | -15 | |||||
| 5Y Average FCF | $3B | 14.0% (40.1%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 7.00% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (14.0%) | ||||||||||
| 2026 | $4B | MBG Intrinsic Value | $-43 | ||||||||
| 2027 | $4B | ||||||||||
| 2028 | $5B | ||||||||||
| 2029 | $5B | ||||||||||
| 2030 | $5B | ||||||||||
| 2031 | $5B | ||||||||||
| Terminal Value | $124B | Net Worth/Share | $35 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $105B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $3B | $74 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $19B | WACC | 6.5% | 69 | 76 | 86 | 97 | 113 | |||
| Equity Value | $88B | 7.1% | 60 | 65 | 72 | 81 | 91 | ||||
| Shares Outstanding | 1,185,777,638 | 7.8% | 52 | 56 | 62 | 68 | 76 | ||||
| 8.4% | 46 | 49 | 53 | 58 | 64 | ||||||
| DCF Intrinsic Value | $74 | 9.0% | 41 | 44 | 47 | 51 | 55 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||